{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:10:23Z","timestamp":1792660223528,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemosphere"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.chemosphere.2013.10.005","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T04:45:45Z","timestamp":1384317945000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"special_numbering":"C","title":["The association between PFOA, PFOS and serum lipid levels in adolescents"],"prefix":"10.1016","volume":"98","author":[{"given":"Sarah Dee","family":"Geiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ducatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Frisbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemosphere.2013.10.005_b0005","unstructured":"American Heart Association. American Heart Association scientific position: cholesterol and atherosclerosis in children. <http:\/\/www.americanheart.org\/presenterjhtml?identifier=44992012> (accessed 19.10.09)."},{"issue":"23","key":"10.1016\/j.chemosphere.2013.10.005_b0010","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.chemosphere.2013.10.005_b0015","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003\u20132004 and Comparisons with NHANES 1999\u20132000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.chemosphere.2013.10.005_b0020","unstructured":"National Center for HEalth Statistics-CDC. Data documentation, codebook, and frequences. 2010. <http:\/\/www.cdc.gov\/nchs\/nhanes\/nhanes2007-2008\/PFC_E.htm>."},{"key":"10.1016\/j.chemosphere.2013.10.005_b0025","unstructured":"National Center for Health Statistics-CDC. Analytical and reporting guidelines for NHANES. <http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_03_04\/nhanes_analytic_guidelines_dec_2005pdf>. (accessed 22.10.10)."},{"issue":"3","key":"10.1016\/j.chemosphere.2013.10.005_b0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/JOM.0b013e3181965d80","article-title":"Thirty years of medical surveillance in perfluooctanoic acid production workers","volume":"51","author":"Costa","year":"2009","journal-title":"J. Occup. Environ. Med."},{"issue":"1","key":"10.1016\/j.chemosphere.2013.10.005_b0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in childhood","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.chemosphere.2013.10.005_b0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.jom.0000233380.13087.37","article-title":"Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters","volume":"48","author":"Emmett","year":"2006","journal-title":"J. Occup. Environ. Med."},{"issue":"9","key":"10.1016\/j.chemosphere.2013.10.005_b0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/archpediatrics.2010.163","article-title":"Perfluorooctanoic acid, perfluorooctane sulfonate, and serum lipids in children and adolescents: results from the C8 Health Project","volume":"164","author":"Frisbee","year":"2010","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"1","key":"10.1016\/j.chemosphere.2013.10.005_b0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.chemosphere.2013.10.005_b0055","unstructured":"National Heart Lung and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH, Publication No. 02-5215 2002."},{"issue":"11","key":"10.1016\/j.chemosphere.2013.10.005_b0060","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/01.CIR.0000061521.15730.6E","article-title":"American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood","volume":"107","author":"Kavey","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.chemosphere.2013.10.005_b0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.2012.9136","article-title":"Trends in serum lipids among US youths aged 6 to 19 years, 1988\u20132010","volume":"308","author":"Kit","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chemosphere.2013.10.005_b0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPAR alpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.chemosphere.2013.10.005_b0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chemosphere.2013.10.005_b0080","unstructured":"National Center for Health Statistics-CDC. National Health and Nutrition Examination Survey 2003\u20132004: reference manuals and reports. <http:\/\/www.cdcgov\/nchs\/nhanes\/nhanes2003-2004\/nhanes03_04htm> (accessed 22.10.10)."},{"key":"10.1016\/j.chemosphere.2013.10.005_b0085","unstructured":"National Center for Health Statistics-CDC. National Health and Nutrition Examination Survey, 2003\u20132004. <http:\/\/www.cdcgov\/nchsnhaneshtm2004> (accessed 25.10.11)."},{"key":"10.1016\/j.chemosphere.2013.10.005_b0090","unstructured":"National Center for Health Statistics-CDC. Procedures for Laboratory Components of NHANES. <http:\/\/www.cdcgov\/nchs\/data\/nhanes\/nhanes_03_04\/blood03_04pdf>. (accessed 22.10.10)."},{"issue":"2","key":"10.1016\/j.chemosphere.2013.10.005_b0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1289\/ehp.0901165","article-title":"Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population","volume":"118","author":"Nelson","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.chemosphere.2013.10.005_b0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1388-1981(99)00024-4","article-title":"Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes","volume":"1437","author":"Okochi","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.chemosphere.2013.10.005_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00420-007-0213-0","article-title":"Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers","volume":"81","author":"Olsen","year":"2007","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"10","key":"10.1016\/j.chemosphere.2013.10.005_b0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/JOM.0b013e318156eca3","article-title":"Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers","volume":"49","author":"Sakr","year":"2007","journal-title":"J. Occup. Environ. Med."},{"issue":"8","key":"10.1016\/j.chemosphere.2013.10.005_b0120","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/JOM.0b013e318124a93f","article-title":"Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate","volume":"49","author":"Sakr","year":"2007","journal-title":"J. Occup. Environ. Med."},{"issue":"8","key":"10.1016\/j.chemosphere.2013.10.005_b0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1289\/ehp.0901827","article-title":"Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)","volume":"118","author":"Steenland","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.chemosphere.2013.10.005_b0130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/aje\/kwp279","article-title":"Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant","volume":"170","author":"Steenland","year":"2009","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl. 1","key":"10.1016\/j.chemosphere.2013.10.005_b0135","doi-asserted-by":"crossref","first-page":"I145","DOI":"10.1016\/0021-9150(89)90171-8","article-title":"Treatment of familial hypercholesterolemia with drugs in children","volume":"9","author":"Stein","year":"1989","journal-title":"Arteriosclerosis"}],"container-title":["Chemosphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653513013775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653513013775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T17:23:05Z","timestamp":1539192185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045653513013775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":26,"alternative-id":["S0045653513013775"],"URL":"https:\/\/doi.org\/10.1016\/j.chemosphere.2013.10.005","relation":{},"ISSN":["0045-6535"],"issn-type":[{"value":"0045-6535","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between PFOA, PFOS and serum lipid levels in adolescents","name":"articletitle","label":"Article Title"},{"value":"Chemosphere","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemosphere.2013.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}